About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Washington | 675 Studies

Clinical Trials Prostate CancerWashington

Prostate Cancer Clinical Trials in Washington

Find 675 clinical trials for prostate cancer near Washington. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 675 trials

CompletedA Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)The main purpose of this study is to establish a recommended dose of Alpharadin to be used in combination with docetaxel in patients with bone metastases from castration-resistant…NCT01106352·San Francisco, California and 6 others TerminatedSafety Study of MGD009 in B7-H3-expressing TumorsThe purpose of this study is to evaluate the safety of MGD009 when given to patients with B7-H3-expressing tumors.NCT02628535·Los Angeles, California and 19 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPatient-Reported Outcome Measurement Information System (PROMIS) Physical FunctionThe objective of this study is to conduct in-person qualitative interviews of subjects who have different tumor types to identify and assess relevant PROMIS physical function…NCT03351140·Mountlake Terrace, Washington

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

CompletedHormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT01546987·Birmingham, Alabama and 171 others

CompletedCarbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the BoneRATIONALE: Imaging procedures, such as PET scan, may help doctors predict a patient's response to treatment and help plan the best treatment.NCT00392938·Seattle, Washington and 1 other

CompletedA Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate CancerBNIT-PR-001 is an open-label, multi-center, Phase I dosing evaluation trial of MVA-BN®-PRO in men with androgen-insensitive prostate cancer.NCT00629057·Homewood, Alabama and 6 others

UnknownPre-operative Education Modalities to Decrease Opioid UseThis is a triple-armed, randomized, controlled, non-blinded trial to study the effect of preoperative patient education in conjunction with a limited opioid peri-operative…NCT04933084·Seattle, Washington

RecruitingProstate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL StudyThis study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive).NCT04472338·Duarte, California and 7 others

TerminatedDurvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen LoadThis phase II trial studies how well durvalumab and olaparib work in treating prostate cancer in men predicted to have specific genetic mutations (a high neoantigen load).NCT04336943·Seattle, Washington

CompletedLow Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate CancerThe primary purpose of this study is to evaluate two treatment regimens for prostate cancer, prostate implant with 20 Gy of external beam radiation therapy versus prostate implant…NCT00241384·Seattle, Washington and 1 other

CompletedSafety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate CarcinomaThe study will evaluate if Leuprolide Mesylate is safe and effective in the treatment of subjects with advanced prostate carcinoma, when administered as two injections six months…NCT02234115·Homewood, Alabama and 28 others

CompletedAbiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerThis is a phase 3 study to compare the clinical benefit of abiraterone acetate plus prednisone with placebo plus prednisone in asymptomatic or mildly symptomatic patients with…NCT00887198·Birmingham, Alabama and 133 others

CompletedA Study of MDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesTo evaluate the safety, tolerability, efficacy, and pharmacokinetics of MDX-1106 when administered to patients with advanced non-small cell lung cancer, colorectal cancer…NCT00441337·Baltimore, Maryland and 3 others

TerminatedA Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate CancerThis is a study to test the safety and efficacy of an investigational chemotherapy agent in patients with advanced prostate cancer.NCT00780975·Ann Arbor, Michigan and 1 other

CompletedTesting the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringThis is a phase I-II trial to find the safety and activity of adding a new drug (neraparib) to the usual treatment (radiation combined with male hormone deprivation therapy) in…NCT04037254·Gilbert, Arizona and 94 others

CompletedRadiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyRATIONALE: Specialized radiation therapy that delivers a high-dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.NCT00528866·Phoenix, Arizona and 69 others

CompletedStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesThis is a Phase 2 study to evaluate the efficacy and safety of cabozantinib (XL184) in subjects with selected advanced tumor types.NCT00940225·Scottsdale, Arizona and 46 others

CompletedPDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesThe purpose of this signal seeking study is to determine whether treatment with PDR001 and LAG525 demonstrates sufficient efficacy in advanced malignancies to warrant further…NCT03365791·San Francisco, California and 19 others

Active not recruitingStudy of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate CancerThe primary objective of this study is to compare the progression free survival (PFS) of patients with metastatic castration-resistant prostate cancer treated with enzalutamide in…NCT02452008·Washington D.C., District of Columbia and 3 others

PreviousPage 10 of 34Next

Other Conditions in Washington

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma